Literature DB >> 3860005

Transformation of myeloma into Ph1-negative CML with plasma cell antigens.

E Paietta, M Goldstein, P Papenhausen, N Ciobanu, P H Wiernik.   

Abstract

We report a patient in whom Ph1-negative chronic myelogenous leukemia (CML) developed 15 years after the diagnosis of myeloma. Combined staining of morphologically myeloid elements in the peripheral blood for myeloid and plasmacytoid antigens revealed double-marker expression, suggesting that the two neoplasms arose from a common originator cell.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3860005     DOI： 10.1002/ajh.2830190312

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  3 in total

1.  Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy.

Authors:  P H Wiernik; D Sciortino; E Paietta; P Papenhausen; N Ciobanu; M Roberts
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Plasma cell leukemia with an unusual karyotype and prolonged survival with oral alkylating agent therapy.

Authors:  P H Wiernik; D Sciortino; E Paietta; P Papenhausen; N Ciobanu; M Roberts
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.